ZYNE - Zynerba Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts6665
Avg. Estimate-0.78-0.74-3.11-3.05
Low Estimate-0.96-0.96-3.57-4.34
High Estimate-0.69-0.59-2.73-2.57
Year Ago EPS-0.64-0.63-2.48-3.11
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts6665
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.6-0.59-0.6-0.66
EPS Actual-0.64-0.63-0.6-0.91
Difference-0.04-0.040-0.25
Surprise %-6.70%-6.80%0.00%-37.90%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.78-0.74-3.11-3.05
7 Days Ago-0.77-0.75-3.12-2.94
30 Days Ago-0.77-0.76-3.15-3.01
60 Days Ago-0.76-0.76-3.1-2.97
90 Days Ago-0.69-0.73-2.8-2.63
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A112
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesZYNEIndustrySectorS&P 500
Current Qtr.-21.90%N/AN/A0.43
Next Qtr.-17.50%N/AN/A0.47
Current Year-25.40%N/AN/A0.22
Next Year1.90%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A